Kelly M T, White A
J Clin Invest. 1973 Aug;52(8):1834-40. doi: 10.1172/JCI107365.
The role of cyclic AMP in histamine release induced by human leukocyte lysates was investigated. Leukocytes were incubated with leukocyte lysates prepared by ultrasonic disruption, and histamine was determined fluorimetrically. Several cyclic AMP-active agents had a marked inhibitory effect on histamine release. Theophylline and isoproterenol produced 50% inhibition at concentrations of less than 10(-5) M. Prostaglandin E(1) and dibutyryl cyclic AMP inhibited release by 50% at 7 x 10(-8) M and 6 x 10(-5) M concentrations, respectively. Histamine, which has recently been shown to increase leukocyte cyclic AMP, had a pronounced inhibitory effect on lysate-induced histamine release, producing 50% inhibition at a concentration of only 2.5 x 10(-12) M.Leukocytes, incubated with leukocyte lysates, were sampled at various times and assayed for free histamine released into the incubation mixture supernates, and for bound histamine associated with the leukocyte buttons after centrifugation. Theophylline, prostaglandin E(1) and dibutyryl cyclic AMP not only blocked histamine release, but also caused a progressive decrease in free histamine when added at any time up to 30 min after initiation of the release reaction. As the free histamine decreased after addition of the inhibitors, there was a corresponding increase in the bound histamine, suggesting that previously released histamine was reabsorbed by the leukocytes after exposure to cyclic AMP-active agents. Continued incubation of leukocytes in their own histamine after completion of the release reaction also resulted in reabsorption of the previously released histamine. Previous studies have indicated that cyclic AMP inhibits leukocyte histamine release. The results of the present studies suggest that cyclic AMP modulates histamine release induced by human leukocyte lysates by stimulating reabsorption of histamine from the extracellular environment. These studies also suggest that previously released extracellular histamine may stimulate its own reabsorption by increasing the intracellular level of cyclic AMP.
研究了环磷酸腺苷(cAMP)在人白细胞裂解物诱导的组胺释放中的作用。将白细胞与通过超声破碎制备的白细胞裂解物一起孵育,并用荧光法测定组胺。几种具有cAMP活性的药物对组胺释放有显著的抑制作用。茶碱和异丙肾上腺素在浓度低于10^(-5)M时产生50%的抑制作用。前列腺素E1和二丁酰环磷酸腺苷分别在7×10^(-8)M和6×10^(-5)M浓度时抑制释放50%。最近已证明能增加白细胞cAMP的组胺,对裂解物诱导的组胺释放有明显的抑制作用,在仅2.5×10^(-12)M的浓度时产生50%的抑制作用。将与白细胞裂解物一起孵育的白细胞在不同时间取样,测定释放到孵育混合物上清液中的游离组胺,以及离心后与白细胞沉淀相关的结合组胺。茶碱、前列腺素E1和二丁酰环磷酸腺苷不仅阻断组胺释放,而且在释放反应开始后直至30分钟的任何时间添加时,都会导致游离组胺逐渐减少。随着抑制剂添加后游离组胺减少,结合组胺相应增加,这表明先前释放的组胺在暴露于具有cAMP活性的药物后被白细胞重新吸收。在释放反应完成后,白细胞在其自身组胺中继续孵育也导致先前释放的组胺被重新吸收。先前的研究表明cAMP抑制白细胞组胺释放。本研究结果表明,cAMP通过刺激组胺从细胞外环境的重新吸收来调节人白细胞裂解物诱导的组胺释放。这些研究还表明,先前释放到细胞外的组胺可能通过增加细胞内cAMP水平来刺激其自身的重新吸收。